Cargando…
Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
BACKGROUND: Chemotherapy with docetaxel (Doc) remains the standard treatment for metastatic and castration-resistance prostate cancer (CRPC). However, the clinical success of Doc is limited by its chemoresistance and side effects. This study investigated whether natural products green tea (GT) and q...
Autores principales: | Wang, Piwen, Henning, Susanne M., Magyar, Clara E., Elshimali, Yahya, Heber, David, Vadgama, Jaydutt V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858851/ https://www.ncbi.nlm.nih.gov/pubmed/27151407 http://dx.doi.org/10.1186/s13046-016-0351-x |
Ejemplares similares
-
Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor
por: Hao, Qiongyu, et al.
Publicado: (2020) -
Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
por: Wang, Piwen, et al.
Publicado: (2010) -
Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN
por: Wu, Yanyuan, et al.
Publicado: (2013) -
Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies
por: Hao, Qiongyu, et al.
Publicado: (2022) -
CCL2/CCR2 signaling in cancer pathogenesis
por: Hao, Qiongyu, et al.
Publicado: (2020)